CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists

Journal of Molecular Modeling

Volumn 8, Issue 10, 2002, Pages 290-301

  Datar, Prasanna ^a   Desai, Prashant ^a,b   Coutinho, Evans ^a   Iyer, Krishna ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

AT1 receptor antagonists; CoMFA; CoMSIA; Consensus dynamics

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAZOLE DERIVATIVE; IMIDAZOPYRIDINE DERIVATIVE; LOSARTAN; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; QUINAZOLINONE DERIVATIVE; RENIN; RENIN INHIBITOR;

COMPUTER AIDED DESIGN; COMPUTER MODEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG ACTIVITY; DRUG CONFORMATION; DRUG STRUCTURE; ELECTROCHEMISTRY; HYDROGEN BOND; INTERMETHOD COMPARISON; MOLECULAR DYNAMICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; STATISTICAL PARAMETERS; STEREOCHEMISTRY; VALIDATION PROCESS;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CIRCULAR DICHROISM; MODELS, MOLECULAR; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 0036979645     PISSN: 16102940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00894-002-0097-6     Document Type: Review

References (54)

1. Vallotton MB (1987) Trends Pharmacol Sci 8:69-74
2. McAreavey DW, Robertson JIS (1990) Drugs 40:326-345
3. Greenlee WJ (1990) Med Res Rev 10:173-236
4. Duncia JV, Carini DJ, Chiu AT, Johnson AL, Price WA, Timmermans PBMWM, Wong PC (1992) Med Res Rev 12:149-191
5. Belvisi L, Bravi G, Scolastico C, Vulpetti A, Salimbeni A, Todeschini R (1994) J Comput-Aided Mol Des 8:211-220
6. Belvisi L, Bravi G, Catalano G, Mabilia M, Salimbeni A, Scolastico C (1996) J Comput-Aided Mol Des 10:567-582
7. Prendergast K, Adams K, Greenlee WJ, Nachbar RB, Patchett AA, Underwood DJ (1994) J Comput-Aided Mol Des 8:491-512
8. Perkins TDJ, Dean PM (1993) J Comput-Aided Mol Des 7:155-172
9. Cramer RD, Patterson DE, Bunce JD (1988) J Am Chem Soc 110:5959-5967
10. Bohm M, Sturzebecher J, Klebe G (1999) J Med Chem 42:458-477
11. Klebe G, Abraham U, Mietzner T (1994) J Med Chem 37:4130-4146
12. Naylor EM, Chakravarty PK, Costello AC, Chang RS, Chen T, Faust KA, Lotti VJ, Kivlighn SD, Zingaro G J, Siegl PKS, Pancras CW, Carini DJ, Wexler AA Greenlee WJ (1994) Bioorg Med Chem Lett 4:69-74
13. Wallace TA, Steven MH, Greenlee WJ, Doss GA, Chang RSL, Lotti VJ, Faust KA, Chen T, Zingaro GJ, Kivlighn SD, Siegl PKS (1993) J Med Chem 36:3595-3605
14. Chakravarty PK, Naylor EM, Chang RSL, Chen A, Chen T, Faust KA, Lotti VJ, Kivlighn SD, Zingaro GJ, Schorn TW, Schaffer LW, Siegl PKS, Patchett AA Greenlee WJ (1994) J Med Chem 37:4068-4072
15. Mantlo NB, Chakravarty PK, Ondeyka DL, Siegl PKS, Chang RSL, Lotti VJ, Faust KA, Chen T, Schorn TW, Sweet CS, Emmert SE, Patchett AA, Greenlee WJ (1991) J Med Chem 34:2919-2922
16. Dhanoa DS, Bagley SW, Chang RSL, Lotti VJ, Chen T, Siegl PKS, Chakravarty PK, Patchett AA, Greenlee WJ (1993) J Med Chem 36:3738-3742
17. Dhanoa DS, Bagley SW, Chang RSL, Lotti VJ, Chen T, Siegl PKS, Zingaro GJ, Patchett AA, Greenlee WJ (1993) J Med Chem 36:4230-4238
18. Linda LC, Wallace TA, Flanagan KL, Chen T, Zingaro GJ, Siegl PKS, Kivlighn SD, Lotti VJ, Chang RSL, Greenlee WJ (1994) J Med Chem 37:4464-4478
19. Linda LC, Flanagan KL, Wallace TA, Naylor EM, Chakravarty PK, Patchett AA, Greenlee WJ, Chen T, Faust KA, Chang RSL, Lotti VJ, Zingaro GJ, Siegl PKS, Kivlighn SD (1994) J Med Chem 37:2808-2824
20. Linda LC, Wallace TA, Flanagan KL, Greenlee WJ, Chang RSL, Lotti VJ, Faust KA, Chen T, Zingaro GJ, Kivlighn SD, Siegl PKS, Bunting P, MacCoss M, Strelitz RA (1993) J Med Chem 36:2558-2568
21. Linda LC, Wallace TA, Flanagan KL, Chen T, Zingaro GJ, Siegl PKS, Lotti VJ, Chang RSL, Greenlee WJ, O'Malley SS (1995) J Med Chem 38:3741-3758
22. Linda LC, Wallace TA, Cantone CL, MacCoss SS, Chang RSL, Lotti VJ, Faust KA, Chen T, Strelitz RA, Bunting P, Kivlighn SD, Siegl PKS (1993) J Med Chem 36:591-609
23. Matter H, Schwab W, Barbier D, Billen G, Hasse B, Neises B, Schudok M, Thorwort W, Schreuder H, Lonze P (1999) J Med Chem 42:1908-1920
24. Marshall GR, Barry CD, Bosshard HE, Dammkoehler RA, Dunn DA (1979) The conformational parameter in drug design: active analog approach. In Olson EC, Christoffersen RE (eds) Computer-assisted drug design. American Chemical Society, Washington, D.C., pp 205-226
25. Cramer RD, Clark M, Simeroth P, Patterson DE (1991) Recent developments in comparative molecular field analysis (CoMFA). In Silipo C, Vittoria A (eds) QSAR: rational approaches to the design of bioactive compounds. Elsevier, Amsterdam, pp 239-242
26. Kamath S, Coutinho E (1997) J Biosci 22:315-324
27. McDowell RS, Gadek TR, Barker PL, Burdick DL, Chan KS, Quan CL (1994) J Am Chem Soc 116:5069-5076
28. Dauber-Osguthorpe P, Roberts VA, Osguthorpe DJ, Wolff J, Genest M, Hagler AT (1988) Proteins: Struct Funct Gen 4:31-47
29. Verlet L (1967) Phys Rev 159:98-103
30. Berendsen HJC, Postma JPM, Van Gunsteren WF, DiNola A, Haak JR (1984) J Chem Phys 81:3684-3690
31. Murtaugh F (1983) Comput J 26:354-359
32. Rappe AK, Casewit CJ, Colwell KS, Goddard WA, Skiff WM, (1992) J Am Chem Soc 114:10024-10035
33. Gasteiger J, Marsili M (1980) Tetrahedron 36:3219-3228
34. Tripos (2001) SYBYL 6.7 Force field manual. Tripos, St Louis, Mo., 290 pp
35. Stewart JJP (1990) J Comput-Aided Mol Des 4:1-103
36. Cho SJ, Tropsha A (1995) J Med Chem 38:1060-1066
37. Bush BL, Nachbar RB (1993) J Comput-Aided Mol Des 7:587-619
38. Wold S, Johansson E, Cocchi M (1993) PLS - partial least-squares projections to latent structures. In Kubinyi H (ed) 3D-QSAR in drug design: theory methods and applications. ESCOM, Leiden, The Netherlands, pp 523-550
39. Leger C, Politis DN, Romano JP (1992) Technometrics 34:378-399
40. 2 guided region selection for CoMFA studies. In Kubinyi H, Folkers G, Martin YC (eds) 3D QSAR methodology CoMFA and related approaches, vol III. Kluwer, Dordrecht, The Netherlands, pp 57-69
41. Allen EE, deLaszlo SE, Huang SX, Quagliato CS, Greenlee WJ, Chen RT, Faust KA, Lotti VJ (1993) Bioorg Med Chem Lett 3:1293-1296
42. Bagley S, Greenlee WJ, Dhanoa DS, Patchett AA (1992) US Patent 5,175,164
43. Glinka TW, deLaszlo SE, Siegl PKS, Chang RSL, Kivlighn SD, Schorn TS, Faust KA, Chen TB, Zingaro GJ, Lotti VJ, Greenlee WJ (1991) Bioorg Med Chem Lett 4:81-84
44. Chakravarty PK, Camara VJ, Chen A, Marcin LM, Greenlee WJ, Patchett AA, Chang RSL, Lotti VJ, Siegl, PKS (1990) 200th National Meeting of the American Chemical Society. American Chemical Society, Washington, D.C., pp 26-31
45. Chakravarty PK, Patchett AA, Camara VJ, Walsh TF, Greenlee WJ (1990) European Patent Application 400,835
46. Ondeyka DL, Mantlo NB, Chakravarty PK, Chen A, Camara VJ, Chang RSL, Lotti VJ, Siegl PKS, Patchett AA, Greenlee WJ (1991) Joint Central-Great Lakes Regional Meeting of the American Chemical Society, Indianapolis, 31 May. American Chemical Society, Washington D.C.
47. Chakravarty PK, Greenlee WJ, Mantlo NB, Patchett AA, Walsh TF (1990) European Patent Application 400,974
48. Allen EE, Huang SX, Chang RSL, Lotti VJ, Siegl PKS, Patchett AA, Greenlee WJ (1991) 202nd National Meeting of the American Chemical Society, New York, August 25-30
49. Patchett AA, Mantlo NB, Greenlee WJ (1992) US Patent 5,124,335
50. Greenlee WJ, Johnston DBR, MacCoss M, Mantlo NB, Patchett AA, Chakravarty PK, Walsh TF (1992) US Patent 5,164,407
51. Allen EE, Greenlee WJ, Chakravarty PK, Patchett AA, Walsh TF (1992) US Patent 5,100,897
52. Huang, HC, Reitz PB, Chamberlain TS, Olins GM, Corpus VM, McMohan EG, Palomo MA, Koepae JP, McGraw DE (1993) J Med Chem 36:2174-2181
53. Yanagisawa H, Amemiya Y, Kanazakai T, Shimoji Y, Fujimoto K, Kitahara Y, Sada T, Mizuno M, Ikeda M, Koike H (1996) J Med Chem 39:323-338
54. Kubo K, Inada Y, Kohara Y, Sugiura Y, Ojima M, Itoh K, Furukawa Y, Nishikawa K, Naka T (1993) J Med Chem 36:1772-1784